New therapeutic agents for peptic ulcer.
D000818:Animals; D004035:Diet Therapy; D004054:Diethylstilbestrol / Q000627:therapeutic use; D005500:Follow-Up Studies; D005750:Gastric Juice; D006035:Glycyrrhiza; D006168:Guinea Pigs; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008970:Molecular Weight; D010146:Pain / Q000188:drug therapy; D010276:Parasympatholytics / Q000627:therapeutic use; D010434:Pepsin A / Q000037:antagonists & inhibitors; D010437:Peptic Ulcer / Q000188:drug therapy*; D010946:Plants, Medicinal; D011134:Polysaccharides / Q000627:therapeutic use; D051381:Rats; D012008:Recurrence; D013431:Sulfates / Q000627:therapeutic use; D015043:Zollinger-Ellison Syndrome / Q000188:drug therapy
D010276:Parasympatholytics; D011134:Polysaccharides; D013431:Sulfates; D004054:Diethylstilbestrol; D006493:Heparin; D010434:Pepsin A